Celldex Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic from 2010 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Celldex Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2010 to 2023.
  • Celldex Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 66.3K shares, a 40.3% increase year-over-year.
  • Celldex Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 48.4K shares, a 3.33% increase from 2022.
  • Celldex Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 46.9K shares, a 9.37% increase from 2021.
  • Celldex Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 42.9K shares, a 44.6% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 48.4K +1.56K +3.33% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-26
2022 46.9K +4.02K +9.37% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 42.9K +13.2K +44.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 29.6K +15.1K +104% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 14.5K Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2011 39.5M* +7.63M Jan 1, 2011 Dec 31, 2011 10-K 2012-03-08
2010 31.9M Jan 1, 2010 Dec 31, 2010 10-K 2012-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.